{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:01:37Z","timestamp":1792123297221,"version":"4.4.0"},"reference-count":128,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C10847\/A27781"],"award-info":[{"award-number":["C10847\/A27781"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate of less than 8%, and is predicted to become the second leading cause of cancer-related death by 2030. Alongside late detection, which impacts upon surgical treatment, PDAC tumours are challenging to treat due to their desmoplastic stroma and hypovascular nature, which limits the effectiveness of chemotherapy and radiotherapy. Pancreatic stellate cells (PSCs), which form a key part of this stroma, become activated in response to tumour development, entering into cross-talk with cancer cells to induce tumour cell proliferation and invasion, leading to metastatic spread. We and others have shown that Fibroblast Growth Factor Receptor (FGFR) signalling can play a critical role in the interactions between PDAC cells and the tumour microenvironment, but it is clear that the FGFR signalling pathway is not acting in isolation. Here we describe our current understanding of the mechanisms by which FGFR signalling contributes to PDAC progression, focusing on its interaction with other pathways in signalling networks and discussing the therapeutic approaches that are being developed to try and improve prognosis for this terrible disease.<\/jats:p>","DOI":"10.3390\/cells10040847","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T10:34:39Z","timestamp":1617878079000},"page":"847","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer"],"prefix":"10.3390","volume":"10","author":[{"given":"Edward P.","family":"Carter","sequence":"first","affiliation":[{"name":"Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail S.","family":"Coetzee","sequence":"additional","affiliation":[{"name":"Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7897-8891","authenticated-orcid":false,"given":"Elena","family":"Tomas Bort","sequence":"additional","affiliation":[{"name":"Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoying","family":"Wang","sequence":"additional","affiliation":[{"name":"Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6771-1905","authenticated-orcid":false,"given":"Hemant M.","family":"Kocher","sequence":"additional","affiliation":[{"name":"Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4738-0173","authenticated-orcid":false,"given":"Richard P.","family":"Grose","sequence":"additional","affiliation":[{"name":"Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/13651820701883148","article-title":"Analysis of mortality rates for pancreatic cancer across the world","volume":"10","author":"Hariharan","year":"2008","journal-title":"HPB Off. J. Int. Hepato Pancreato Biliary Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/annonc\/mdt301","article-title":"Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980","volume":"24","author":"Bosetti","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic Adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2015.02.043","article-title":"Homeostatic restoration of desmoplastic stroma rather than its ablation slows pancreatic cancer progression","volume":"148","author":"Froeling","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.pan.2016.05.393","article-title":"Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma","volume":"16","author":"Arumugam","year":"2016","journal-title":"Pancreatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Clear","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/path.4172","article-title":"Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes","volume":"230","author":"Kadaba","year":"2013","journal-title":"J. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e26788","DOI":"10.4161\/onci.26788","article-title":"The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration","volume":"2","author":"Watt","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3748\/wjg.v22.i9.2678","article-title":"Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells","volume":"22","author":"Nielsen","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/jcb.21209","article-title":"Stromal biology of pancreatic cancer","volume":"101","author":"Chu","year":"2007","journal-title":"J. Cell Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2011.06.047","article-title":"Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-beta-catenin signaling to slow tumor progression","volume":"141","author":"Froeling","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.cell.2016.05.079","article-title":"Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation","volume":"165","author":"Tape","year":"2016","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MPA.0b013e318214efaf","article-title":"Analysis of the human pancreatic stellate cell secreted proteome","volume":"40","author":"Wehr","year":"2011","journal-title":"Pancreas"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cytogfr.2012.07.001","article-title":"Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2)","volume":"24","author":"Charrier","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3390\/cancers2031661","article-title":"Interaction of Stellate Cells with Pancreatic Carcinoma Cells","volume":"2","author":"Habisch","year":"2010","journal-title":"Cancers"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1158\/1535-7163.MCT-06-0686","article-title":"Tumor-stroma interactions in pancreatic ductal adenocarcinoma","volume":"6","author":"Mahadevan","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e48780","DOI":"10.15252\/embr.201948780","article-title":"High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1","volume":"21","author":"Steins","year":"2020","journal-title":"EMBO Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Adams, S.D., Csere, J., D\u2019Angelo, G., Carter, E.P., Romao, M., Arnandis, T., Dodel, M., Kocher, H.M., Grose, R., and Raposo, G. (2021). Centrosome amplification mediates small extracellular vesicle secretion via lysosome disruption. Curr. Biol.","DOI":"10.1101\/2020.08.19.257162"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12630","DOI":"10.1038\/ncomms12630","article-title":"ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion","volume":"7","author":"Chronopoulos","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e46556","DOI":"10.15252\/embr.201846556","article-title":"GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment","volume":"20","author":"Cortes","year":"2019","journal-title":"EMBO Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1038\/s41467-020-18636-w","article-title":"Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer","volume":"11","author":"Kocher","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e12605","DOI":"10.1111\/cpr.12605","article-title":"Deciphering role of FGFR signalling pathway in pancreatic cancer","volume":"52","author":"Kang","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-12-385233-5.00002-7","article-title":"Molecular biology of pancreatic ductal adenocarcinoma progression: Aberrant activation of developmental pathways","volume":"97","author":"Rhim","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/emmm.201302698","article-title":"Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion","volume":"6","author":"Coleman","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: From development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_30","first-page":"5289","article-title":"Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage","volume":"53","author":"Yamanaka","year":"1993","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.humpath.2015.07.022","article-title":"Clinicopathological significance of fibroblast growth factor 1 in non-small cell lung cancer","volume":"46","author":"Li","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00006676-200305000-00006","article-title":"Expressions of angiogenic factors in pancreatic ductal carcinoma: A correlative study with clinicopathologic parameters and patient survival","volume":"26","author":"Kuwahara","year":"2003","journal-title":"Pancreas"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1200\/JCO.2008.21.5988","article-title":"Pancreatic endocrine tumors: Expression profiling evidences a role for AKT-mTOR pathway","volume":"28","author":"Missiaglia","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004280050074","article-title":"Expression of basic fibroblast growth factor (FGF-2)-associated with tumour proliferation in human pancreatic carcinoma","volume":"431","author":"Yamazaki","year":"1997","journal-title":"Virchows Arch."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1006\/bbrc.1994.1611","article-title":"The gradient of basic fibroblast growth factor concentration in human pancreatic cancer cell invasion","volume":"200","author":"Hasegawa","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ijc.2910590515","article-title":"Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer","volume":"59","author":"Leung","year":"1994","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1054\/bjoc.2001.1813","article-title":"FGF-1 and FGF-2 modulate the E-cadherin\/catenin system in pancreatic adenocarcinoma cell lines","volume":"84","author":"Pignatelli","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ijc.1515","article-title":"FGF-1 and FGF-2 regulate the expression of E-cadherin and catenins in pancreatic adenocarcinoma","volume":"94","author":"Pignatelli","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<555::AID-IJC18>3.0.CO;2-H","article-title":"FGF-2 isoforms of 18 and 22.5 kDa differentially modulate t-PA and PAI-1 expressions on the pancreatic carcinoma cells AR4-2J: Consequences on cell spreading and invasion","volume":"85","author":"Escaffit","year":"2000","journal-title":"Int. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/sj.onc.1201307","article-title":"Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: Evidence for autocrine and paracrine actions","volume":"15","author":"Kornmann","year":"1997","journal-title":"Oncogene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/IJGC:29:2:085","article-title":"Expression of the IIIc Variant of FGF Receptor-1 Confers Mitogenic Responsiveness to Heparin and FGF-5 in TAKA-1 Pancreatic Ductal Cells","volume":"29","author":"Kornmann","year":"2001","journal-title":"Int. J. Gastrointest. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1074\/jbc.M606878200","article-title":"Keratinocyte growth factor\/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappaB transcription factors","volume":"282","author":"Niu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bjc.6604473","article-title":"FGF10\/FGFR2 signal induces cell migration and invasion in pancreatic cancer","volume":"99","author":"Nomura","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/MPA.0000000000000155","article-title":"Serum cytokine profile in patients with pancreatic cancer","volume":"43","author":"Torres","year":"2014","journal-title":"Pancreas"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1134\/S1607672918040105","article-title":"Variable Effects of Growth Factors on Developmental Gene Expression in Pancreatic Cancer Cells","volume":"481","author":"Gnatenko","year":"2018","journal-title":"Dokl. Biochem. Biophys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archsurg.134.3.245","article-title":"Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer","volume":"134","author":"Vickers","year":"1999","journal-title":"Arch. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1158\/0008-5472.CAN-05-2926","article-title":"Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon","volume":"66","author":"Tassi","year":"2006","journal-title":"Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1242\/dmm.023184","article-title":"Echoes of the embryo: Using the developmental biology toolkit to study cancer","volume":"9","author":"Aiello","year":"2016","journal-title":"Dis. Models Mech."},{"key":"ref_49","first-page":"4741","article-title":"Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas","volume":"53","author":"Kobrin","year":"1993","journal-title":"Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/bjc.1995.420","article-title":"Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas","volume":"72","author":"Ohta","year":"1995","journal-title":"Br. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/35083041","article-title":"N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling","volume":"3","author":"Cavallaro","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/cas.12470","article-title":"Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer","volume":"105","author":"Matsuda","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1091-255X(02)00036-7","article-title":"Ligand activation of alternatively spliced fibroblast growth factor receptor-1 modulates pancreatic adenocarcinoma cell malignancy","volume":"6","author":"Vickers","year":"2002","journal-title":"J. Gastrointest. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ajpath.2012.01.020","article-title":"Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation","volume":"180","author":"Ishiwata","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1158\/0008-5472.CAN-06-3843","article-title":"Identification of a fibroblast growth factor receptor 1 splice variant that inhibits pancreatic cancer cell growth","volume":"67","author":"Liu","year":"2007","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/sj.bjc.6605440","article-title":"Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: Modulation by FGFR1-III isoform expression","volume":"102","author":"Chen","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_57","first-page":"1604","article-title":"Interactions of pancreatic cancer and stellate cells are mediated by FGFR1-III isoform expression","volume":"59","author":"Tian","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/gutjnl-2018-317706","article-title":"Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes","volume":"68","author":"Maurer","year":"2019","journal-title":"Gut"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1242\/dev.023176","article-title":"Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development","volume":"135","author":"Brugmann","year":"2008","journal-title":"Development"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ydbio.2008.04.009","article-title":"An FGF-WNT gene regulatory network controls lung mesenchyme development","volume":"319","author":"Yin","year":"2008","journal-title":"Dev. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1073\/pnas.1007417108","article-title":"FGF4 and FGF8 comprise the wavefront activity that controls somitogenesis","volume":"108","author":"Naiche","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1242\/dev.009167","article-title":"FGF signaling acts upstream of the NOTCH and WNT signaling pathways to control segmentation clock oscillations in mouse somitogenesis","volume":"134","author":"Wahl","year":"2007","journal-title":"Development"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.2337\/diabetes.54.10.2844","article-title":"Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function","volume":"54","author":"Papadopoulou","year":"2005","journal-title":"Diabetes"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.emboj.7600460","article-title":"FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development","volume":"24","author":"Chamorro","year":"2005","journal-title":"EMBO J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.devcel.2017.09.003","article-title":"Fgf10-Hippo Epithelial-Mesenchymal Crosstalk Maintains and Recruits Lung Basal Stem Cells","volume":"43","author":"Volckaert","year":"2017","journal-title":"Dev. Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1083\/jcb.132.6.1105","article-title":"Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus","volume":"132","author":"Fagotto","year":"1996","journal-title":"J. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Kam, Y., and Quaranta, V. (2009). Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: Evidence for an intersection between beta-catenin pools. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004580"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1002\/jcb.27266","article-title":"Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt\/\u03b2-catenin pathway in pancreatic cancer cells","volume":"119","author":"Cao","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","article-title":"E-cadherin is required for metastasis in multiple models of breast cancer","volume":"573","author":"Padmanaban","year":"2019","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ahmed, S., Bradshaw, A.D., Gera, S., Dewan, M.Z., and Xu, R. (2017). The TGF-\u03b2\/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance. J. Clin. Med., 6.","DOI":"10.3390\/jcm6010005"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0002-9440(10)61125-X","article-title":"Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis","volume":"160","author":"Shek","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Porcelli, L., Iacobazzi, R.M., Di Fonte, R., Serrat\u00ec, S., Intini, A., Solimando, A.G., Brunetti, O., Calabrese, A., Leonetti, F., and Azzariti, A. (2019). CAFs and TGF-\u03b2 Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine\/Nabpaclitaxel in Pancreatic Cancer. Cancers, 11.","DOI":"10.3390\/cancers11030330"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"33407","DOI":"10.1038\/srep33407","article-title":"Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF\u03b2)-dependent smooth muscle cell phenotype modulation","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"712","DOI":"10.15252\/emmm.201506181","article-title":"Smooth muscle FGF\/TGF\u03b2 cross talk regulates atherosclerosis progression","volume":"8","author":"Chen","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.celrep.2014.09.020","article-title":"The tumor suppressor Smad4\/DPC4 is regulated by phosphorylations that integrate FGF, Wnt, and TGF-\u03b2 signaling","volume":"9","author":"Demagny","year":"2014","journal-title":"Cell Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e1025181","DOI":"10.1080\/23723556.2015.1025181","article-title":"Point mutations in the tumor suppressor Smad4\/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-\u03b2 signaling","volume":"3","author":"Demagny","year":"2016","journal-title":"Mol. Cell. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7555\/JBR.30.20150107","article-title":"Deciphering the role of hedgehog signaling in pancreatic cancer","volume":"30","author":"Gu","year":"2016","journal-title":"J. Biomed. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1158\/1535-7163.MCT-08-0573","article-title":"An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer","volume":"7","author":"Feldmann","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0960-9822(06)00340-X","article-title":"Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas","volume":"7","author":"Apelqvist","year":"1997","journal-title":"Curr. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1101\/gad.12.11.1705","article-title":"Notochord repression of endodermal Sonic hedgehog permits pancreas development","volume":"12","author":"Hebrok","year":"1998","journal-title":"Genes Dev."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Watson, B.A., Feenstra, J.M., Van Arsdale, J.M., Rai-Bhatti, K.S., Kim, D.J.H., Coggins, A.S., Mattison, G.L., Yoo, S., Steinman, E.D., and Pira, C.U. (2018). LHX2 Mediates the FGF-to-SHH Regulatory Loop during Limb Development. J. Dev. Biol., 6.","DOI":"10.3390\/jdb6020013"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Dettmer, R., Cirksena, K., M\u00fcnchhoff, J., Kresse, J., Diekmann, U., Niwolik, I., Buettner, F.F.R., and Naujok, O. (2020). FGF2 Inhibits Early Pancreatic Lineage Specification during Differentiation of Human Embryonic Stem Cells. Cells, 9.","DOI":"10.3390\/cells9091927"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-3-030-40146-7_8","article-title":"The Role of Glypican-1 in the Tumour Microenvironment","volume":"1245","author":"Lund","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Valle, S., Martin-Hijano, L., Alcal\u00e1, S., Alonso-Nocelo, M., and Sainz, B. (2018). The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer. Cancers, 10.","DOI":"10.3390\/cancers10020033"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10585-018-9919-5","article-title":"The therapeutic targeting of the FGFR1\/Src\/NF-kappaB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity","volume":"35","author":"Lai","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fcell.2020.00287","article-title":"An FGFR\/AKT\/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness","volume":"8","author":"Quan","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1078-0432.CCR-06-0436","article-title":"The Use of Targeted Mouse Models for Preclinical Testing of Novel Cancer Therapeutics","volume":"12","author":"Olive","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccr.2012.10.025","article-title":"Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma","volume":"22","author":"Kopp","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/onc.2017.393","article-title":"SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer","volume":"37","author":"Zhou","year":"2018","journal-title":"Oncogene"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1073\/pnas.97.3.1113","article-title":"Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway","volume":"97","author":"Murakami","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/gene.20093","article-title":"Normal lung development and function after Sox9 inactivation in the respiratory epithelium","volume":"41","author":"Perl","year":"2005","journal-title":"Genesis"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/372525a0","article-title":"Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene","volume":"372","author":"Foster","year":"1994","journal-title":"Nature"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/hmg\/ddq558","article-title":"SOX9 controls epithelial branching by activating RET effector genes during kidney development","volume":"20","author":"Reginensi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1242\/dev.078733","article-title":"A Sox9\/Fgf feed-forward loop maintains pancreatic organ identity","volume":"139","author":"Seymour","year":"2012","journal-title":"Development"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1158\/2159-8290.CD-19-0435","article-title":"MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype","volume":"10","author":"Sodir","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S., Oon, C., Kothari, A., Horton, W., Link, J., Sears, R.C., and Sherman, M.H. (2020). Acidic fibroblast growth factor underlies microenvironmental regulation of MYC in pancreatic cancer. J. Exp. Med., 217.","DOI":"10.1084\/jem.20191805"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Mahe, M., Dufour, F., Neyret-Kahn, H., Moreno-Vega, A., Beraud, C., Shi, M., Hamaidi, I., Sanchez-Quiles, V., Krucker, C., and Dorland-Galliot, M. (2018). An FGFR3\/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers. EMBO Mol. Med., 10.","DOI":"10.15252\/emmm.201708163"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tcb.2014.11.003","article-title":"Careless talk costs lives: Fibroblast growth factor receptor signalling and the consequences of pathway malfunction","volume":"25","author":"Carter","year":"2015","journal-title":"Trends Cell Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1158\/1535-7163.MCT-11-0450","article-title":"Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models","volume":"11","author":"Gozgit","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1158\/1535-7163.MCT-17-0009","article-title":"Cotargeting of MEK and PDGFR\/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma","volume":"16","author":"Sahu","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_105","unstructured":"(2021, March 25). NCT02265341. Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT02265341."},{"key":"ref_106","unstructured":"(2021, March 25). NCT01888965. Maintenance Dovitinib for Colorectal and Pancreas Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01888965."},{"key":"ref_107","unstructured":"(2021, March 25). NCT02048943. Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02048943."},{"key":"ref_108","unstructured":"(2021, March 25). NCT01497392. Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01497392."},{"key":"ref_109","unstructured":"NCT02108782 (2021, March 25). Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02108782."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1158\/1535-7163.MCT-11-0312","article-title":"Targeting FGFR\/PDGFR\/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer","volume":"10","author":"Taeger","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/bjc.2013.754","article-title":"Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models","volume":"110","author":"Zhang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/COC.0000000000000492","article-title":"A Phase Ib Study of the FGFR\/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients","volume":"42","author":"Ma","year":"2019","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2014.12.027","article-title":"Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer","volume":"358","author":"Awasthi","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1158\/1535-7163.MCT-12-0995","article-title":"BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer","volume":"12","author":"Ostapoff","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1158\/1078-0432.CCR-14-3036","article-title":"Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model","volume":"21","author":"Bill","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_116","unstructured":"(2021, March 25). NCT02902484. Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02902484."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2045-824X-6-18","article-title":"Lenvatinib, an angiogenesis inhibitor targeting VEGFR\/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage","volume":"6","author":"Yamamoto","year":"2014","journal-title":"Vasc. Cell"},{"key":"ref_118","unstructured":"(2021, March 25). NCT02678780. Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors (TALENT), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02678780."},{"key":"ref_119","unstructured":"(2021, March 25). NCT03797326. Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080\/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005\/E7080-G000-224\/LEAP-005), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03797326."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1593\/neo.06616","article-title":"Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer","volume":"9","author":"Buchler","year":"2007","journal-title":"Neoplasia"},{"key":"ref_121","first-page":"2303","article-title":"A potential novel therapy for FGFR1-amplified pancreatic cancer with bone metastasis, screened by next-generation sequencing and a patient-derived xenograft model","volume":"17","author":"Guan","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2217\/fon-2020-0299","article-title":"Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions\/translocations: The PROOF 301 trial","volume":"16","author":"Makawita","year":"2020","journal-title":"Future Oncol."},{"key":"ref_123","unstructured":"(2021, March 25). NCT02575508. Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02575508."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ccr.2013.02.018","article-title":"Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling","volume":"23","author":"Herbert","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ccr.2013.02.019","article-title":"Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties","volume":"23","author":"Bono","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Raj, D., Nikolaidi, M., Garces, I., Lorizio, D., Castro, N.M., Caiafa, S.G., Moore, K., Brown, N.F., Kocher, H.M., and Duan, X. (2021). CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal Adenocarcinoma. Clin. Cancer Res.","DOI":"10.1158\/1078-0432.CCR-19-2163"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/path.5224","article-title":"Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma","volume":"248","author":"Neuzillet","year":"2019","journal-title":"J. Pathol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2017.02.028","article-title":"Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas","volume":"174","author":"Neuzillet","year":"2017","journal-title":"Pharmacol. Ther."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/4\/847\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:34:29Z","timestamp":1760362469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/4\/847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":128,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["cells10040847"],"URL":"https:\/\/doi.org\/10.3390\/cells10040847","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}